GlassScriptPhysician profile
John P Ranonis
NPI 1013047745
$1,444.09
in general payments reported to CMS, 2019-2025
9 companies · $20.60 in 2025
The $20.60 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $855 · 2022: $22.93 · 2023: $179 · 2024: $367 · 2025: $20.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.15 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $855.00 | 2021 | |
| Ethicon US, LLC | $222.85 | 2023-2024 | Stratafix, Dermabond, Surgicel Nu-Knit |
| Medical Device Business Services, INC. | $137.01 | 2024 | Surgicel Nu-Knit |
| Avita Medical Americas, LLC | $118.96 | 2024 | |
| Baxter Healthcare | $30.00 | 2023 | Tisseel |
| Integra Lifesciences Corporation | $22.93 | 2022 | |
| Smith+Nephew, INC. | $20.60 | 2025 | Collagenase Santyl |
| Kci USA, INC. | $18.49 | 2023 | V.A.C.Ulta, Prevena, Abthera |
| Becton, Dickinson and Company | $18.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ranonis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.